Jennie Olofsson

6PUBLICATIONS
51CO-AUTHORS
Neurology and neuromuscular diseasesInnate immunityMedical genetics (excl. cancer genetics)Memory and attentionPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 22, 2024
Cerebrospinal fluid levels of NfM in relation to NfL and pNfH as prognostic markers in amyotrophic lateral sclerosis.

Jennie Olofsson, Sofia Bergström, Sára Mravinacová

|Aug 30, 2021
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.

Sebastian Havervall, Henry Ng, August Jernbom Falk

|Jul 23, 2021
Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay.

Sophia Hober, Cecilia Hellström, Jennie Olofsson

|Jun 15, 2021
Multi-cohort profiling reveals elevated CSF levels of brain-enriched proteins in Alzheimer's disease.

Sofia Bergström, Julia Remnestål, Jamil Yousef

|Jun 03, 2021
Publisher Correction: Altered perivascular fibroblast activity precedes ALS disease onset.

Anna Månberg, Nathan Skene, Folkert Sanders

|Apr 16, 2021
Altered perivascular fibroblast activity precedes ALS disease onset.

Anna Månberg, Nathan Skene, Folkert Sanders

Pageof 1